A method of permanent transvenous implantation of an atrial electrode. Am Heart J 85: 195, 1973 fluoroscopic visualization into the right atrium, and with the aforementioned bends in the electrode the catheter is directed away from the tricuspid valve and into the coronary sinus. The characteristic superior direction of the electrode in the coronary vein is well described in previous reports.2 3The fluoroscopic time for positioning the catheter in the coronary vein is generally less than five minutes. After the catheter is in the mid portion of the coronary vein, the stylets are withdrawn and the threshold for pacing is determined for the unipolar proximal (ring) and distal (tip) electrodes and for the bipolar configuration. The lowest atrial pacing thresholds have generally been obtained from the unipolar ring electrode. A threshold of less than 3 milliamps for atrial pacing is optimal, and if higher thresholds are evident the catheter is either advanced further into the coronary vein or withdrawn slightly from its prior position to obtain a lower threshold. Unipolar and bipolar pulse generators have been utilized, and satisfactory atrial pacing has been achieved with Medtronic, Cordis, and Cardiac Pacemaker pulse generators.
Subsequent reports during the period from 1970 to 1974 documented the safety of this procedure in a relatively small number of patients. 2 4 We have also reported on the usefulness of the coronary vein atrial pacing technique in the termination and inhibition of recurrent supraventricular tachycardia. 5 Since the original article in 1968, we have implanted pervenous atrial pacemakers in the coronary vein in 50 patients. This report details the effectiveness of this pervenous atrial pacing technique during the past ten years.
Methods
Details of the method of implanting a permanent coronary venous atrial pacemaker have been described previously from this laboratory.' Presently, the most effective technique for introducing the catheter into the coronary vein utilizes a left cephalic vein approach. With rare exceptions, Medtronic model 5818 and 6904 bipolar catheters have been utilized. A gentle 600 bend 6 cm back from the tip of the electrode and an additional J bend at the electrode tip are made with the stylets in the catheter before insertion of the electrode into the vein. The catheter is advanced under available Medtronic 5950, Cordis 162 and CPI 602 pulse generators have been utilized without difficulty. A total of 11 electrode related malpacing events occurred in the ten-year period with a malpacing event rate of 10% in the first pacing month, 1.1% per paced month during the next six months, and 0.25% per paced month thereafter. Life table analysis reveals that effective atrial pacing was achieved in 76% of the patients during a follow-up of more than five years. This experience substantiates the long-term safety and effectiveness of atrial pacing from the coronary vein using standard pacemaker electrodes and generators.
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Results
The clinical characteristics of the 50 patients with implanted atrial pacemakers are presented in table 1. The mean age of the patients was 68 years; 60% were males. The major indication for atrial pacing was symptomatic sinus bradycardia (72%); 20% had the atrial brady-tachy syndrome, and 8% required atrial pacing for inhibition or termination of intractable or recurrent tachyarrhythmias (ventricular fibrillation in three and paroxysmal supraventricular The total electrode-related malpacing events, i.e., those unrelated to primary generator dysfunction, are presented in table 3 . The malpacing events are not uniformly distributed over time, but rather are concentrated in the early postimplantation period. Of 11 malpacing events, five occurred within the first postimplantation month, three occurred in the next six months, and the remaining three occurred between 9 and 33 months after insertion. Electrode dislodgement out of the coronary vein occurred in four patients, a high early threshold in three, and the remaining four events included one temporary malsensing problem, one electrode wire break, and two paced PR interval prolongations of greater than 0.24 sec. The rate of malpacing events averaged 10% during the first implantation month, 1.1% per paced month during the next six months, and 0.25% per paced month thereafter. An actuarial analysis6 of the effectiveness of atrial pacing over time is presented graphically in figure 1.
Eleven patients died in this series during the 10 year experience, and pacemaker malfunction could not be implicated as the cause of death in any patient. Six patients died with chronic end-stage congestive heart failure, two with documented acute myocardial infarction, and three with problems unrelated to their chronic cardiac disease. Five of the eleven patients died during hospitalizations remote from the initial implantation procedure from problems unrelated to the pacemaker. In each case effective atrial pacing was documented during the terminal episode. positioned in the right atrial appendage for atrial sensing and pacing. Electrode dislodgement has been a troublesome problem, but ongoing modification of the electrode configuration and further clinical experience have substantiated the potential usefulness of these right atrial approaches.12 14 Other pervenous methods using atrioventricular electrodes", and electrodes with barbs and hooks for atrial fixation have had only limited trials. 16 Eleven malpacing events were observed in the 50 reported patients during 1531 atrial pacing months for an average event rate of 0.72% per paced month. In the seven patients with either electrode dislodgement out of the coronary vein or the development of a high threshold, the initial atrial pacing threshold averaged 4.4 ± 2.8 ma, a value almost twice that of our entire series. As indicated in the Methods section, our current procedure is to strive for an atrial pacing threshold of less than 3.0 ma at the time of initial implantation. With higher thresholds, inconstant pacing is likely to develop. It should be noted that the average threshold for atrial pacing increased by only 1.3 ma between initial implantation and subsequent battery replacement two to four years later. This small increment is similar to that observed with ventricular pacing.
The life table graph ( fig. 1 ) clearly indicates the higher problem rate during the first few months after implantation with a subsequent performance which is excellent. Over 75% of the patients had effective atrial pacing five years after implantation of the coronary vein electrode.
Atrial pacemakers have special usefulness in selected clinical problems. Although many patients with symptomatic sinus bradycardia can be paced effectively with ventricular electrodes, atrial pacing often improves the hemodynamic state by enhancing atrial contribution to ventricular performance.17 The preservation of the normal sequential relationship between atrial and ventricular contraction is especially important in patients with atrial bradycardia and associated myocardial disease. Atrial pacing is most helpful in improving the quality of life in this group. Three patients in this series with symptomatic sinus bradycardia originally had ventricular pacemakers implanted, but subsequently required conversion to atrial pacing because of hypotension and low cardiac output. The clinical situation significantly improved after the atrial pacing.
In some patients with the atrial brady-tachy syndrome with normal atrioventricular conduction, ventricular pacing has inadvertently induced recurrent re-entrant tachycardia. Atrial pacing is especially indicated in this clinical situation for not only are the ventricular pacemaker-induced tachycardias avoided, but also atrial pacing may inhibit the expression of the atrial tachycardia.
Although our experience is limited, atrial pacing has controlled intractable supraventricular and ventricular tachyarrhythmias in four patients.5 With clearer understanding of the re-entrant mechanism in many tachyarrhythmias, the authors suspect that atrial pacemakers will have increasing applicability in the management of troublesome reciprocating supraventricular tachycardias. ' unchanged. However, the arterial PO, decreased from a mean of 80 ± 3 (SEM) to 72 ± 2 mm Hg (P < 0.001) and mean venous admixture increased from 8.8 ± 1% to 12.6 ± 1.5% (P < 0.001). The alveolararterial P02 difference increased (P < 0.001) and the dead space tidal volume ratio rose (P < 0.05). We conclude that the decrease in arterial P02 following sublingual nitroglycerin is caused by redistribution of pulmonary blood flow with imbalance in ventilation-perfusion relationships or shunting.
The purpose of the present study was to investigate the possible effects of an even more widely used vasodilator, sublingual nitroglycerin, on the resting pulmonary gas exchange and simultaneous hemodynamics in man.
Patients and Methods
Nineteen male patients aged 26 to 70, admitted for evaluation of chest pain syndromes, were the subjects of this study. Five patients were normal, 11 had coronary artery disease (including four with abnormal left ventriculograms), two had primary myocardial disease, and one had rheumatic mitral regurgitation.
The studies were performed in the postabsorptive state in the cardiac catheterization laboratory during the course of right and left heart catheterization and coronary arteriography. Prior informed consent was obtained appropriately. Patients were in the supine position and were breathing room air during the entire procedure. All hemodynamic and blood gas data were obtained before the
